Literature DB >> 3029395

Serological survey for human monkeypox infections in a selected population in Zaire.

Z Jezek, J H Nakano, I Arita, M Mutombo, M Szczeniowski, C Dunn.   

Abstract

About 3460 persons living in Kole zone of East Kasai, in Zaire, were examined and their sera screened initially by a haemagglutination-inhibition test. Of these, 667 (19%) were positive. Radioimmunoassay adsorption tests for the presence of monkeypox- or vaccinia-specific antibodies gave unequivocal results in 300 of these sera; the remaining 47 were nonspecific. Monkeypox-specific antibodies were found in sera of 27 individuals, of all ages and both sexes, giving an overall prevalence rate of monkeypox virus-specific antibodies of 0.8%. The prevalence rate was four times higher in the 5 to 9 year age group (1.3%) than in children aged 0 to 4 years (0.3%), and was highest (2.4%) in the 15 to 19 year age group. There was no significant difference in the prevalence rates between the sexes. As might be expected, there are substantially higher prevalence rates in persons living in forest galleries than in those in savannah, and among those living in areas where human monkeypox cases had occurred in the past compared with those living in other localities. Nineteen children whose sera showed specific monkeypox antibodies were re-examined. Twelve showed facial and body skin changes suggesting the presence of vesiculo-pustular disease in the past; four of these had been known registered monkeypox cases. Seven children had neither signs nor history of past vesiculo-pustular disease, suggesting that they had suffered from subclinical infection with monkeypox virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029395

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  18 in total

1.  Assessment of the protective effect of Imvamune and Acam2000 vaccines against aerosolized monkeypox virus in cynomolgus macaques.

Authors:  Graham J Hatch; Victoria A Graham; Kevin R Bewley; Julia A Tree; Mike Dennis; Irene Taylor; Simon G P Funnell; Simon R Bate; Kimberley Steeds; Thomas Tipton; Thomas Bean; Laura Hudson; Deborah J Atkinson; Gemma McLuckie; Melanie Charlwood; Allen D G Roberts; Julia Vipond
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  A silent enzootic of an orthopoxvirus in Ghana, West Africa: evidence for multi-species involvement in the absence of widespread human disease.

Authors:  Mary G Reynolds; Darin S Carroll; Victoria A Olson; Christine Hughes; Jack Galley; Anna Likos; Joel M Montgomery; Richard Suu-Ire; Mubarak O Kwasi; J Jeffrey Root; Zach Braden; Jason Abel; Cody Clemmons; Russell Regnery; Kevin Karem; Inger K Damon
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

3.  Optimization of peptide-based ELISA for serological diagnostics: a retrospective study of human monkeypox infection.

Authors:  Melissa E Dubois; Erika Hammarlund; Mark K Slifka
Journal:  Vector Borne Zoonotic Dis       Date:  2012-01-04       Impact factor: 2.133

4.  characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak.

Authors:  Kevin L Karem; Mary Reynolds; Zach Braden; Gin Lou; Nikeva Bernard; Joanne Patton; Inger K Damon
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

5.  Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

Authors:  Anne W Rimoin; Prime M Mulembakani; Sara C Johnston; James O Lloyd Smith; Neville K Kisalu; Timothee L Kinkela; Seth Blumberg; Henri A Thomassen; Brian L Pike; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Barney S Graham; Pierre Formenty; Emile Okitolonda; Lisa E Hensley; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

6.  Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.

Authors:  Irith De Baetselier; Christophe Van Dijck; Chris Kenyon; Jasmine Coppens; Johan Michiels; Tessa de Block; Hilde Smet; Sandra Coppens; Fien Vanroye; Joachim Jakob Bugert; Philipp Girl; Sabine Zange; Laurens Liesenborghs; Isabel Brosius; Johan van Griensven; Philippe Selhorst; Eric Florence; Dorien Van den Bossche; Kevin K Ariën; Antonio Mauro Rezende; Koen Vercauteren; Marjan Van Esbroeck
Journal:  Nat Med       Date:  2022-08-12       Impact factor: 87.241

Review 7.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

8.  Using remote sensing to map the risk of human monkeypox virus in the Congo Basin.

Authors:  Trevon Fuller; Henri A Thomassen; Prime M Mulembakani; Sara C Johnston; James O Lloyd-Smith; Neville K Kisalu; Timothee K Lutete; Seth Blumberg; Joseph N Fair; Nathan D Wolfe; Robert L Shongo; Pierre Formenty; Hermann Meyer; Linda L Wright; Jean-Jacques Muyembe; Wolfgang Buermann; Sassan S Saatchi; Emile Okitolonda; Lisa Hensley; Thomas B Smith; Anne W Rimoin
Journal:  Ecohealth       Date:  2010-11-11       Impact factor: 3.184

Review 9.  Qualitative assessment of risk for monkeypox associated with domestic trade in certain animal species, United States.

Authors:  Susan M Bernard; Steven A Anderson
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

10.  Spectrum of infection and risk factors for human monkeypox, United States, 2003.

Authors:  Mary G Reynolds; Whitni B Davidson; Aaron T Curns; Craig S Conover; Gregory Huhn; Jeffrey P Davis; Mark Wegner; Donita R Croft; Alexandra Newman; Nkolika N Obiesie; Gail R Hansen; Patrick L Hays; Pamela Pontones; Brad Beard; Robert Teclaw; James F Howell; Zachary Braden; Robert C Holman; Kevin L Karem; Inger K Damon
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.